Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Enterovirus Type 71 Vaccine, Inactivated in Healthy Children Aged 6~71 Months: A Single-armed Bridging Clinical Trial

NCT07793175 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT07793175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Enterovirus Type 71 Vaccine, Inactivated in Healthy Children Aged 6~71 Months: A Single-armed Bridging Clinical Trial
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 19, 2026
Completion date
July 16, 2027
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enterovirus 71 infection, hand, foot, and mouth disease (hfmd)